This guideline covers assessing and managing oesophago-gastric cancer in adults, including radical and palliative treatment and nutritional support.
Shire plc reported positive top-line results from a 39-week, long-term maintenance of efficacy study of Vyvanse (lisdexamfetamine dimesylate) Capsules (CII)...
Shire plc has announced that the FDA has accepted for filing with priority review a supplemental New Drug Application (sNDA)...
This guideline covers rehabilitation strategies for adults who have experienced a critical illness and stayed in critical care.
It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.
Shire plc has announced that the FDA approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the...
We examined the influence of depression and anxiety on executive function in individuals with a DSM-IV diagnosis of anorexia...
Shire plc has announced positive top-line results from two identically designed randomized placebo-controlled Phase III studies evaluating the efficacy and...
Sunovion Pharmaceuticals announced that a study (SEP360-321) evaluating the efficacy and safety of dasotraline in adults (18 to 55 years...
Vernalis plc and Tris Pharma, Inc. announce that the FDA has accepted the CCP-07 New Drug Application (�NDA�) for full...